+Vote!
PR News Wire (Free subscription) | 08/01/2008
- Company Raises Annual Revenue and EPS Guidance -
BRAINTREE, Mass., August 1 /PRNewswire-FirstCall/ -- Haemonetics
Corporation (NYSE: ) today reported first quarter fiscal 2009 GAAP net
revenues of $144 million, up 18%; operating income of $19 million, up 23%;
and net earnings per share of $0.54, up 17%.
Excluding charges in both fiscal 2008 and 2009, first quarter fiscal
2009 adjusted operating...
1Vote!
PR News Wire (Free subscription) | 07/07/2008
BRAINTREE, Mass., July 7 /PRNewswire-FirstCall/ -- Haemonetics
Corporation (NYSE: ) will announce its Q1FY09 earnings on August 1, 2008
in a pre-market press release and 10:00 am (EDT) conference call.
Conference Call Dial-In Information
(888) 802-8577 (US & Canada)
(973) 935-8754 (International)
ID #: 54880152
This call will be replayed through August 15, 2008 at 5:00 pm (EDT). To
access the...
+Vote!
PR News Wire (Free subscription) | 06/25/2008
BRAINTREE, Mass., June 25 /PRNewswire-FirstCall/ -- Haemonetics
Corporation (NYSE: ) announced today that Chris Lindop, Chief Financial
Officer and Vice President, Business Development, will present at the
Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, 2008.
The public may access Mr. Lindop's presentation live via webcast at
. The webcast will be archived and
available through...
+Vote!
PR News Wire (Free subscription) | 06/16/2008
BRAINTREE, Ma., June 16 /PRNewswire-FirstCall/ -- Haemonetics
Corporation announced today at the annual meeting of the Plasma Protein
Therapeutics Association the launch of a plasma collection software for its
PCS(R)2 plasma collection system that reduces plasma donation time by 20%.
Stephen Swenson, General Manager of Global Plasma for Haemonetics,
said, "This new software system, with its faster...
+Vote!
PR News Wire (Free subscription) | 05/29/2008
BRAINTREE, Mass., May 29 /PRNewswire-FirstCall/ -- Haemonetics
Corporation and Octapharma AG announced today the signing of a multi-year
supply contract appointing Haemonetics as Octapharma's preferred provider
of plasma collection technology in the United States. Under the agreement,
Octapharma will use Haemonetics' technology to separate plasma from donor
blood at its U.S. plasma collection centers....
+Vote!
PR News Wire (Free subscription) | 05/19/2008
BRAINTREE, Mass., May 19 /PRNewswire-FirstCall/ -- Haemonetics
Corporation announced today that it will host an investor meeting on
Thursday, May 29th at the New York Stock Exchange.
The agenda for the meeting includes:
-- Fiscal 2009 annual operating plan review
-- Fiscal 2009 transformational restructuring
-- Blood Management Solutions strategy
-- R&D review
The meeting is scheduled from...
+Vote!
Seeking Alpha (Free subscription) | 05/13/2008
Haemonetics Corp. (HAE) F4Q08 (Qtr End 03/29/08) Earnings Call Complete Story ยป
+Vote!
PR News Wire (Free subscription) | 05/06/2008
BRAINTREE, Mass., May 6 /PRNewswire-FirstCall/ -- Haemonetics
Corporation announced today that Brad Nutter, Chairman and CEO, has adopted
a pre-arranged stock trading plan under Rule 10b5-1 of the Securities
Exchange Act of 1934.
Rule 10b5-1 plans allow executives to adopt a pre-arranged stock
trading plan to buy or sell a specified number of shares of the company's
stock. Under the plan, Mr. Nutter...
+Vote!
PR News Wire (Free subscription) | 04/07/2008
BRAINTREE, Mass., April 7, 2008 /PRNewswire-FirstCall/ -- Haemonetics
Corporation (NYSE: ) will announce its Q4FY08 and FYE08 earnings on May
1, 2008 in a pre-market press release and 10:00 am (EDT) conference call.
Conference Call Dial-In Information
(888) 802-8577 (US & Canada)
(973) 935-8754 (International)
ID: 42384135
This call will be replayed through May 16, 2008 at 5:00 pm (EDT). To
access...
+Vote!
Business Wire (Free subscription) | 04/03/2008
CHICAGO--(BUSINESS WIRE)--Zacks.com releases the latest list of Zacks Rank Buy Stocks. Every day on
+Vote!
PR News Wire (Free subscription) | 03/19/2008
BRAINTREE, Mass., March 19 /PRNewswire-FirstCall/ -- Haemonetics
Software Solutions is pleased to announce U.S. 510(k) marketing clearance
for eLynx(TM), a paperless data capture and temporary storage system for
use in blood collection centers. eLynx streamlines and consolidates
workflow activities. The automation ensures that standard operating
procedures are followed, reducing the likelihood of errors...
1Vote!
Business Wire (Free subscription) | 03/14/2008
Research and Markets: Gain Insight into Haemonetics, a Global Company that Markets Automated Blood Processing Systems DUBLIN, Ireland--()--Research and Markets () has announced the addition of Haemonetics Corporation Strategic Analysis Profile to their offering. -- This profile is an essential source for data, analysis and strategic insight into this company. The report examines Haemonetics Corporations...
1Vote!
The Boston Business Journal (Free subscription) | 03/12/2008
Haemonetics Corp. said Wednesday that Peter Allen has been appointed to the newly created position of chief marketing officer. (HAE)
+Vote!
PR News Wire (Free subscription) | 03/11/2008
BRAINTREE, Mass., March 11 /PRNewswire-FirstCall/ -- Haemonetics
Corporation announced today the appointment of Peter Allen to the newly
created position of Chief Marketing Officer. In this position, Mr. Allen
will assume responsibility for global marketing of Haemonetics' full
product portfolio in addition to his current responsibilities as President,
Donor Division.
Brian Concannon, Chief Operating...
+Vote!
PR News Wire (Free subscription) | 01/31/2008
- Raises Annual Revenue Growth Guidance -
BRAINTREE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Haemonetics
Corporation (NYSE: ) today reported third quarter fiscal 2008 GAAP net
revenues of $135 million, up 18.6%; net income of $14 million, down 15.1%;
and net earnings per share of $0.54, down 12.1%.
Third quarter fiscal 2008 adjusted net income, excluding charges in
both fiscal 2007 and 2008 and...
